Clinical Trial Update: Cardiovascular Risk Evaluation and Antiretrovirals in HIV

View source ↗

Summary

This is a completed clinical trial sponsored by King's College London evaluating cardiovascular risk in people with HIV receiving antiretroviral therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• HIV Infection

Snippet

Sponsor: King's College London | Conditions: Cardiovascular Risk, HIV Infections | Status: COMPLETED